Actively Recruiting
Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
Led by Rumesa Butt · Updated on 2026-01-30
50
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly associated with gait disturbances, balance impairments, and freezing of gait, which significantly increase the risk of falls and reduce functional independence. Conventional physical therapy improves mobility in individuals with PD; however, persistent gait deficits often remain. Rhythmic Auditory Stimulation (RAS) is an emerging, evidence-based intervention that uses external auditory cues to enhance gait timing, stride length, and movement initiation. This randomized controlled trial aims to evaluate the effectiveness of rhythmic auditory stimulation using personalized music therapy combined with conventional physical therapy compared to conventional physical therapy alone in individuals with Parkinson's disease. The primary outcomes include freezing of gait, gait velocity, and balance performance. Forty-two clinically diagnosed Parkinson's disease patients will be randomly allocated into two groups. Group A will receive conventional physical therapy, while Group B will receive rhythmic auditory stimulation using personalized music in addition to conventional therapy over an 8-week intervention period. The findings of this study may provide clinical evidence supporting the integration of personalized rhythmic auditory stimulation into rehabilitation programs for improving gait and balance in individuals with Parkinson's disease.
CONDITIONS
Official Title
Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Parkinson's disease according to the Queen Square Brain Bank criteria
- Both males and females aged 45 to 55 years
- Mini Mental State Examination (MMSE) score above 23, indicating no severe cognitive impairment
- Able to cooperate with study procedures
- Mild balance impairment with Berg Balance Scale (BBS) score between 21 and 40
You will not qualify if you...
- History of cancer
- Severe cardiovascular, respiratory, visual, auditory, or musculoskeletal diseases
- Other neurological conditions besides Parkinson's disease
- Received neurologic music therapy in the last 3 months
- Any other disorders that could affect balance or walking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shadman Medical Center
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
R
Rumesa Butt, MSPTN
CONTACT
M
Montiha Azeem, MSPTN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here